Shenzhen Chipscreen Biosciences Co. Ltd.SSE: 688321

Announcement on Progress in Repurchasing Shares

Jun 2, 2026 · Issued by Shenzhen Chipscreen Biosciences Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 2, 2026

On 6ix: 6ix.com/news/announcement-on-progress-in-repurchasing-shares-138

Announcement on Progress in Repurchasing Shares

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix

Earlier from Shenzhen Chipscreen Biosciences

Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 5% Integer MultipleMay 23
Indicative Announcement on Pricing for Shareholders' Inquiry-based TransferMay 19
Shareholders' Inquiry Transfer PlanMay 16
Announcement on Voluntary Disclosure of Approval of Chiglitazar Sodium for Market Release by the Pharmaceutical Administration Bureau, Macao SARMay 15
Announcement on Receipt of the "Decision on the Examination of an Invalidity Declaration Request" from the China National Intellectual Property AdministrationMay 9

Later from Shenzhen Chipscreen Biosciences

Announcement on Follow-up Credit Rating Results of "Chipscreen Convertible Bonds"Jun 27
Announcement on Conversion Result of Convertible Bonds and Share ChangesJul 2
Notice on Convening the 1st Extraordinary General Meeting in 2026Jul 16
Announcement on Implementation Result of Shares Repurchase and Share ChangesJul 17
Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of DirectorsJul 27

All Shenzhen Chipscreen Biosciences news releases

Follow Shenzhen Chipscreen Biosciences into a list and get an email when it puts out news.

Follow Shenzhen Chipscreen Biosciences